$ARWR

"ARO-HIF2 is Arrowhead's first therapeutic candidate delivered using a new extra-hepatic delivery vehicle"

$MRK validates the target, w/ small molecule.

RNAi in ccRCC. 'nuff said. 

https://t.co/eJU7pw3S9W https://t.co/E6Nij7YWFA